Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Charming Medical Limited Class A ( (MCTA) ) has provided an update.
On December 23, 2025, Charming Medical Limited received notice that independent director Leut Ming Gung would resign effective December 31, 2025, citing other business commitments and with no disagreement over the company’s operations, policies or procedures; his resignation was formally accepted by the board on January 5, 2026. On the same day, the board and its key committees approved the appointment of fund manager and technology entrepreneur Yin Jiang, 43, as an independent, non-employee director with annual compensation of HK$240,000, naming him chairman of the Compensation Committee and a member of the Audit and Nominating Committees, a move that refreshes the company’s board with expertise in private equity, artificial intelligence, blockchain and high-performance computing and may strengthen its governance profile with U.S. investors and regulators.
More about Charming Medical Limited Class A
Charming Medical Limited is a British Virgin Islands-incorporated company with principal executive offices in Hong Kong. The company is listed in the United States as a foreign private issuer, indicating it operates internationally, though this filing focuses primarily on its corporate governance and board composition rather than its specific medical products or services.
Average Trading Volume: 871,725
Current Market Cap: $504.3M
See more insights into MCTA stock on TipRanks’ Stock Analysis page.